Advertisement

Topics

England starts prioritizing patients amid global hep B vaccine shortage

09:55 EDT 10 Aug 2017 | BioPharmaDive

The decision comes as Merck and GlaxoSmithKline are working to restore vaccine supplies.

Original Article: England starts prioritizing patients amid global hep B vaccine shortage

NEXT ARTICLE

More From BioPortfolio on "England starts prioritizing patients amid global hep B vaccine shortage"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...